Lv21
110 积分 2022-10-24 加入
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
2小时前
待确认
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
8天前
已完结
Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study
8天前
已完结
Updated clinical practice guidelines for the management of adult diffuse gliomas
9天前
已完结
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1
11天前
已完结
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
11天前
已完结
Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
11天前
已完结
Individual Patient Cohort Analysis of the Efficacy of Hypertonic Saline/Dextran in Patients with Traumatic Brain Injury and Hypotension
22天前
已关闭
Estimating the starting dose for entry into humans: principles and practice
2个月前
已完结
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
3个月前
已完结
皖公网安备34019202002308
